Rigel Pharmaceuticals (RIGL) Other Operating Expenses (2013 - 2026)

Rigel Pharmaceuticals' Other Operating Expenses history runs 13 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 4.47% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $19.8 million (down 5.77% YoY), while the FY2025 annual figure was $19.6 million, up 5.22% from the prior year.
• Other Operating Expenses was $4.6 million for Q1 2026 at Rigel Pharmaceuticals, down from $6.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $14.5 million in Q4 2022 to a low of $121000.0 in Q1 2022.
• Historically, Other Operating Expenses has averaged $3.9 million across 5 years, with a median of $3.8 million in 2023.
• Biggest YoY gain for Other Operating Expenses was 707.44% in 2023; the steepest drop was 73.91% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $14.5 million in 2022, then sank by 73.91% to $3.8 million in 2023, then soared by 52.74% to $5.8 million in 2024, then advanced by 2.87% to $6.0 million in 2025, then retreated by 22.65% to $4.6 million in 2026.
• The last three Other Operating Expenses figures came in at $4.6 million (Q1 2026), $6.0 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.